Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (380)	6/12/1998 1:34:00 PM
From: Turboe	Read Replies (1) \| Respond to of 5402

Come on Andrew-- you are a decent person-- not a basher-- why are you here? WE have done out DD-- why do you want to be the whipping boy? Call the company youself-- see if they are excited. You are losing credibility here-- buy some or don't. But do not be Janice Shill-- please...

To: Andrew H who wrote (380)	6/12/1998 1:35:00 PM
From: Gwolf	Read Replies (3) \| Respond to of 5402

You seem to forget that the earlier product was used on over 1500 patients with no problems. This refined product is even better. There is a difference between being skeptical and just plain argumentative. Gwolf

To: Andrew H who wrote (380)	6/12/1998 1:45:00 PM
From: drdan	Respond to of 5402

You are correct, Andew. However, if you go to the fda website and look under human drugs, you will find info that states that the fda is attempting to speed up the process of approval for drgs given for life-threatening circumstances. Some of the HIV drugs were benefactors of this . Now I am not saying that this will be the case with this drug, but I will say that we could call the fda and fnd out whether drug derivatives useful in life threatening situations (such as this one, I presume) can get faster approval. Again , let us collect more facts and then assess the sithuation.